LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $51,171 | $7,845 | $1,346 |
| G&A Expenses | $13,659 | $3,531 | $1,463 |
| SG&A Expenses | $13,659 | $3,531 | $1,463 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $64,830 | $11,376 | $2,809 |
| Operating Income | -$64,830 | -$11,376 | -$2,809 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $1,729 | $5,102 | -$11,538 |
| Pre-Tax Income | -$63,101 | -$6,274 | -$14,347 |
| Tax Expense | $1 | $1 | $1 |
| Net Income | -$63,102 | -$6,275 | -$14,348 |
| % Margin | – | – | – |
| EPS | -17.83 | -1.77 | -4.05 |
| % Growth | -907.3% | 56.3% | – |
| EPS Diluted | -17.83 | -1.77 | -4.05 |
| Weighted Avg Shares Out | 3,540 | 3,541 | 3,541 |
| Weighted Avg Shares Out Dil | 3,540 | 3,541 | 3,541 |
| Supplemental Information | – | – | – |
| Interest Income | $1,721 | $811 | $73 |
| Interest Expense | $0 | $4,825 | $2,151 |
| Depreciation & Amortization | $91 | $4 | $2 |
| EBITDA | -$63,010 | -$1,445 | -$12,194 |
| % Margin | – | – | – |